(2002), it could be implied that the beneficial bioactive effects of lactadherin in inhibiting inflammatory bowels disease pathology could rely less on induction of enterocyte migration and more on phagocytosis of opportunistic pathogens and apoptotic cells as well as induction of immunosuppressing regulatory T cells (Fava & Danese, 2011; Hanayama et al., 2002; Zhou, Gao, Yang, & Yuan, 2010). This evidence concerns the gene MFGE8 and inflammatory bowel disease.